Biome Australia Ltd (BIO) - Total Liabilities
Based on the latest financial reports, Biome Australia Ltd (BIO) has total liabilities worth AU$6.25 Million AUD (≈ $4.42 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Biome Australia Ltd (BIO) cash conversion ratio to assess how effectively this company generates cash.
Biome Australia Ltd - Total Liabilities Trend (2019–2025)
This chart illustrates how Biome Australia Ltd's total liabilities have evolved over time, based on quarterly financial data. Check BIO cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Biome Australia Ltd Competitors by Total Liabilities
The table below lists competitors of Biome Australia Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Laurion Mineral Exploration Inc
V:LME
|
Canada | CA$599.62K |
|
Omax Autos Limited
NSE:OMAXAUTO
|
India | Rs1.71 Billion |
|
Fertilizantes Heringer S.A
SA:FHER3
|
Brazil | R$4.00 Billion |
|
Telomir Pharmaceuticals, Inc. Common Stock
NASDAQ:TELO
|
USA | $1.43 Million |
|
Kedawung Setia Industrial Tbk
JK:KDSI
|
Indonesia | Rp490.81 Billion |
|
Cheche Group Inc. Class A Ordinary Shares
NASDAQ:CCG
|
USA | $943.35 Million |
|
Danen Technology Corp
TW:3686
|
Taiwan | NT$9.62 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down Biome Australia Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BIO stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Biome Australia Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Biome Australia Ltd (2019–2025)
The table below shows the annual total liabilities of Biome Australia Ltd from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$7.29 Million ≈ $5.16 Million |
+35.72% |
| 2024-06-30 | AU$5.37 Million ≈ $3.80 Million |
+35.24% |
| 2023-06-30 | AU$3.97 Million ≈ $2.81 Million |
+130.16% |
| 2022-06-30 | AU$1.73 Million ≈ $1.22 Million |
+87.63% |
| 2021-06-30 | AU$920.00K ≈ $650.96K |
-7.73% |
| 2020-06-30 | AU$997.11K ≈ $705.52K |
+63.24% |
| 2019-06-30 | AU$610.84K ≈ $432.21K |
-- |
About Biome Australia Ltd
Biome Australia Limited engages in the development, commercialization, and marketing of various live biotherapeutics and complementary medicines in Australia and internationally. The company provides probiotics as live biotherapeutic products under the Activated Probiotics brand, and nutraceutical and complementary medicines under the Activated Therapeutics brand. It markets its products through … Read more